The Coverage and Acceptance Spectrum of COVID-19 Vaccines among Healthcare Professionals in Western Tanzania: What Can We Learn from This Pandemic?

The Coverage and Acceptance Spectrum of COVID-19 Vaccines among Healthcare Professionals in Western Tanzania: What Can We Learn from This Pandemic?
复制标题

DOI:
10.3390/vaccines10091429
复制
发表时间:
2022-08-30
期刊:
影响因子:
7.8
通讯作者:
Mshana SE
Mshana SE
中科院分区:
医学3区
文献类型:
--
作者:
Konje ET;Basinda N;Kapesa A;Mugassa S;Nyawale HA;Mirambo MM;Moremi N;Morona D;Mshana SE

文献摘要

参考文献

被引文献

相似文献

由于疫苗犹豫,发展中国家的COVID-19疫苗接种率仍然很低。疫苗犹豫是遏制全球COVID-19大流行的公共卫生威胁。已发现医疗保健专业人员在普通人群中的疫苗宣传和推广活动中发挥着关键作用。在坦桑尼亚COVID-19疫苗接种推广计划的最初几个月进行了一项横断面研究,以确定接受率、感知障碍和行动线索。共有来自坦桑尼亚西部26个卫生设施的811名卫生保健专业人员参加。通过了世界卫生组织(世卫组织)疫苗接受调查问卷,并进行了微小修改,以了解当地情况,并用于数据收集。只有18.5%的医护人员接种了COVID-19疫苗,接受率为29%。大多数(62%)参与者由于缺乏有效沟通和可靠的疗效和安全性信息而处于犹豫阶段。在COVID-19大流行的时代,有必要通过透明的对话让公共卫生人士和意见领袖参与进来,以澄清疫苗相关的安全性、质量和有效性。这些策略将减少误解,不信任,并提高医疗保健专业人员的吸收,并最终在普通人群中。
The vaccination rate against COVID-19 remains low in developing countries due to vaccine hesitancy. Vaccine hesitancy is a public health threat in curbing COVID-19 pandemic globally. Healthcare professionals have been found to play a critical role in vaccine advocacy and promotion campaigns in the general population. A cross sectional study was conducted in the initial months of the COVID-19 vaccination roll out program in Tanzania to determine the acceptance rate, perceived barriers, and cues for actions. A total of 811 healthcare professionals participated from 26 health facilities in western Tanzania. The World Health Organization (WHO) vaccine acceptance questionnaire was adopted with minor modifications to capture the local contexts and used in data collection. Only (18.5%) healthcare professionals had received a COVID-19 vaccine and acceptance rate was 29%. The majority (62%) of participants were in the hesitancy stage due to issues related to lack of effective communication and reliable information regarding efficacy and safety. In this era of COVID-19 pandemic, there is a need to engage and involve public health figures and opinion leaders through transparent dialogue to clarify vaccine-related safety, quality, and efficacy. These strategies will reduce misconception, mistrust, and improve uptake among healthcare professionals and eventually in the general population.
DOI: 10.1016/s0140-6736(21)02507-1
发表时间: 2021-12-11
期刊: Lancet (London, England)
影响因子: --
作者:
Omer SB;Benjamin RM;Brewer NT;Buttenheim AM;Callaghan T;Caplan A;Carpiano RM;Clinton C;DiResta R;Elharake JA;Flowers LC;Galvani AP;Lakshmanan R;Maldonado YA;McFadden SM;Mello MM;Opel DJ;Reiss DR;Salmon DA;Schwartz JL;Sharfstein JM;Hotez PJ
通讯作者: Hotez PJ
DOI: 10.1371/journal.pone.0268711
发表时间: 2022
期刊: PLOS ONE
影响因子: 3.7
作者:
Ackah, Martin;Ameyaw, Louise;Salifu, Mohammed Gazali;Asubonteng, Delali Pearl Afi;Yeboah, Cynthia Osei;Annor, Eugene Narkotey;Ankapong, Eunice Abena Kwartemaa;Boakye, Hosea
通讯作者: Boakye, Hosea
撒哈拉以南非洲疫苗犹豫的评论。
DOI: 10.3390/tropicalmed7070130
发表时间: 2022-07-11
影响因子: 2.9
作者:
通讯作者: --
DOI: 10.1016/j.ajic.2021.04.079
发表时间: 2021-09
影响因子: 4.9
作者:
Dzieciolowska S;Hamel D;Gadio S;Dionne M;Gagnon D;Robitaille L;Cook E;Caron I;Talib A;Parkes L;Dubé È;Longtin Y
通讯作者: Longtin Y
DOI: 10.1186/s13690-021-00686-1
发表时间: 2021-09-18
期刊: Archives of public health = Archives belges de sante publique
影响因子: --
作者:
Kafeero HM;Ndagire D;Ocama P;Kudamba A;Walusansa A;Sendagire H
通讯作者: Sendagire H